U.S. Patent: 5,840,715
Date of Patent: Nov. 24, 1998
Abstract
This invention is directed to a dietary regimen and a unique
combination of nutritional supplements and a method. More specifically,
this invention is directed to a unique combination of nutritional
supplements which provides symptomatic relief from arthritis. The unique
combination of nutritional supplement of this invention is believed to
function by both increasing the available (effective blood level) of
anti-inflammatory agents and promoting of the healing/regenerative
process in the effected joints, thus producing unexpected and lasting
symptomatic relief from the debilitating effects of both osteo-arthritis
and rheumatoid arthritis. The essential nutritional supplements of hte
dietary regimen of this invention are as follows: (a) gamma linolenic
acid (unrefined), hereinafter "GLA"; (b) a mixture of
eicosapentaenoic acid an docosahexaneoic acid, hereinafter collectively
"EPA"; (c) a mixture of chondroitin sulfate, N-acetyl glucosamine
sulfate, glucosamine sulfate and maganese aspartate, hereinafter
collectively "CHONDROX". The regimen is adjusted based upon
the weight of the individual, and once symptomatic relief is achieved,
the individual remains essentially free from the debilitating effects of
arthritis so as long the daily regimen is faithfully followed.
5 Claims, No Drawings
|